Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Australians Move Closer To First Cloning License

This article was originally published in PharmAsia News

Executive Summary

Stem cell researchers at Australia's Monash University moved closer to the possibility of receiving the first license from the government to clone human embryonic cells. The National Health and Medical Research Council held a meeting to consider proposals by Monash and the Australian Stem Cell Centre. If the license is granted, it would be the first since the nation's therapeutic-cloning law went into effect last year. The country also has in place strict guidelines for conducting such research, including a prohibition on implanting such cells into humans. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC068916

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel